Tag results:
lung cancer cells
Pulmonary Cell News
Long Noncoding RNA SH3PXD2A-AS1 Promotes NSCLC Proliferation and Accelerates Cell Cycle Progression by Interacting with DHX9
[Cell Death Discovery] The authors found that SH3PXD2A-AS1 expression in NSCLC tissues was upregulated compared with that in normal lung tissues in The Cancer Genome Atlas database by using the GEPIA website.
Pulmonary Cell News
Vestigial-Like Family Member 3 Stimulates Cell Motility by Inducing High-Mobility Group AT-Hook 2 Expression in Cancer Cells
[Journal of Cellular and Molecular Medicine] Scientists found that A549 human lung cancer cells stably expressing vestigial-like family member 3 exhibited spindle-like morphological changes, reduction in the epithelial marker E-cadherin and induction of the mesenchymal marker Snail.
Pulmonary Cell News
The Cancer/Testis Antigen HORMAD1 Mediates Epithelial–Mesenchymal Transition to Promote Tumor Growth and Metastasis by Activating the Wnt/β-Catenin Signaling Pathway in Lung Cancer
[Cell Death Discovery] The authors demonstrated that HORMAD1 promotes the proliferation, migration and invasion of lung cancer cells both in vitro and in vivo by inducing epithelial–mesenchymal transition.
Pulmonary Cell News
Heterogeneous Nuclear Ribonucleoprotein K Promotes the Progression of Lung Cancer by Inhibiting the p53-Dependent Signaling Pathway
[Thoracic Cancer] Inhibition of progression of lung cancer cells induced by heterogeneous nuclear ribonucleoprotein K-knockdown was dependent on activation of p53 by the p53/p21/cyclin D1 pathway.
Pulmonary Cell News
The Expression of PD-1 Ligand 1 on Macrophages and Its Clinical Impacts and Mechanisms in Lung Adenocarcinoma
[Cancer Immunology Immunotherapy] In an in vitro study using lung cancer cell lines and human monocyte-derived macrophages, the conditioned medium from cancer cells was found to up-regulate programmed cell death-1 ligand 1 expression on macrophages via STAT3 activation.
Cancer Stem Cell News
Low-Temperature Plasma-Activated Medium Inhibited Proliferation and Progression of Lung Cancer by Targeting the PI3K/Akt and MAPK Pathways
[Oxidative Medicine and Cellular Longevity] Scientists explored the effect of the plasma-activated medium on lung cancer cells in vitro and in vivo by using a 3D cell culture model.